Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Terazosin Hydrochloride Patent Expiration

Terazosin Hydrochloride is Used for treating hypertension and symptomatic benign prostatic hyperplasia. It was first introduced by Abbott Laboratories Pharmaceutical Products Div in its drug Hytrin on Aug 7, 1987. Another drug containing Terazosin Hydrochloride is Tezruly. 14 different companies have introduced drugs containing Terazosin Hydrochloride.


Terazosin Hydrochloride Patents

Given below is the list of patents protecting Terazosin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Tezruly US11224572 Stable oral liquid composition of terazosin Jan 18, 2042 Novitium Pharma
Hytrin US5294615 Terazosin polymorph and pharmaceutical composition Apr 29, 2013

(Expired)

 Abbott
Hytrin US5412095 Terazosin monohydrochloride and processes and intermediate for its production Apr 29, 2013

(Expired)

 Abbott



Terazosin Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Terazosin Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Terazosin Hydrochloride. The first generic version for Terazosin Hydrochloride was by Apnar Pharma Lp and was approved on Mar 30, 1998. And the latest generic version is by Ajanta Pharma Ltd and was approved on May 12, 2025.

Given below is the list of companies who have filed for Terazosin Hydrochloride generic, along with the locations of their manufacturing plants worldwide.


1. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE

capsule Prescription ORAL AB May 12, 2025
EQ 2MG BASE

capsule Prescription ORAL AB May 12, 2025
EQ 5MG BASE

capsule Prescription ORAL AB May 12, 2025
EQ 10MG BASE

capsule Prescription ORAL AB May 12, 2025


Manufacturing Plant Locations
New

Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Ajanta Pharma Ltd.





2. APNAR PHARMA LP

Apnar Pharma Lp has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Apnar Pharma Lp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE

capsule Prescription ORAL AB Mar 30, 1998
EQ 2MG BASE

capsule Prescription ORAL AB Mar 30, 1998
EQ 5MG BASE

capsule Prescription ORAL AB Mar 30, 1998
EQ 10MG BASE

capsule Prescription ORAL AB Mar 30, 1998





3. BIONPHARMA

Bionpharma Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB Jul 28, 2000
EQ 5MG BASE

capsule Prescription ORAL AB Jul 28, 2000
EQ 2MG BASE

capsule Prescription ORAL AB Jul 28, 2000
EQ 1MG BASE

capsule Prescription ORAL AB Jul 28, 2000


Manufacturing Plant Locations
New

Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.

Country City Firm Name
United States
Princeton Bionpharma Inc.





4. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Apr 28, 2000
EQ 1MG BASE

tablet Discontinued ORAL N/A Apr 28, 2000
EQ 2MG BASE

tablet Discontinued ORAL N/A Apr 28, 2000
EQ 5MG BASE

tablet Discontinued ORAL N/A Apr 28, 2000





5. HERITAGE PHARMA AVET

Heritage Pharma Labs Inc Dba Avet Pharmaceuticals Labs Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Heritage Pharma Avet.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE

capsule Prescription ORAL AB Jan 30, 2001
EQ 1MG BASE

capsule Prescription ORAL AB Jan 30, 2001
EQ 5MG BASE

capsule Prescription ORAL AB Jan 30, 2001
EQ 10MG BASE

capsule Prescription ORAL AB Jan 30, 2001





6. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE

capsule Discontinued ORAL N/A Apr 12, 2001
EQ 2MG BASE

capsule Discontinued ORAL N/A Apr 12, 2001
EQ 5MG BASE

capsule Discontinued ORAL N/A Apr 12, 2001
EQ 10MG BASE

capsule Discontinued ORAL N/A Apr 12, 2001


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Eatontown Hikma Pharmaceuticals USA, Inc.
Dayton Hikma Injectables USA Inc
Cherry Hill Hikma Pharmaceuticals USA Inc.
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





7. IVAX SUB TEVA PHARMS

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Ivax Sub Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A Apr 21, 2000
EQ 5MG BASE

tablet Discontinued ORAL N/A Apr 21, 2000
EQ 2MG BASE

tablet Discontinued ORAL N/A Apr 21, 2000
EQ 1MG BASE

tablet Discontinued ORAL N/A Apr 21, 2000





8. JUBILANT CADISTA

Jubilant Cadista Pharmaceuticals Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Jubilant Cadista.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Prescription ORAL AB Dec 20, 2004
EQ 5MG BASE

capsule Prescription ORAL AB Dec 20, 2004
EQ 2MG BASE

capsule Prescription ORAL AB Dec 20, 2004
EQ 1MG BASE

(reference standard)

capsule Prescription ORAL AB Dec 20, 2004


Manufacturing Plant Locations
New

Jubilant Cadista's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Jubilant Cadista as present at those locations.

Country City Firm Name
United States
Salisbury Jubilant Cadista Pharmaceuticals, Inc.





9. PHARMOBEDIENT

Pharmobedient Consulting Llc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Pharmobedient.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

capsule Discontinued ORAL N/A Dec 1, 2000
EQ 2MG BASE

capsule Discontinued ORAL N/A Dec 1, 2000
EQ 1MG BASE

capsule Discontinued ORAL N/A Dec 1, 2000
EQ 5MG BASE

capsule Discontinued ORAL N/A Dec 1, 2000





10. RANBAXY LABS LTD

Ranbaxy Laboratories Ltd has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Ranbaxy Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE

capsule Discontinued ORAL N/A Aug 22, 2002
EQ 2MG BASE

capsule Discontinued ORAL N/A Aug 22, 2002
EQ 5MG BASE

capsule Discontinued ORAL N/A Aug 22, 2002
EQ 10MG BASE

capsule Discontinued ORAL N/A Aug 22, 2002





11. SANDOZ

Sandoz Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE

tablet Discontinued ORAL N/A Dec 31, 1998
EQ 2MG BASE

tablet Discontinued ORAL N/A Dec 31, 1998
EQ 5MG BASE

tablet Discontinued ORAL N/A Dec 31, 1998
EQ 10MG BASE

tablet Discontinued ORAL N/A Dec 31, 1998


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
East Hanover Sandoz Incorporated
Princeton Sandoz Inc
Spain
Palafolls Sandoz Industrial Products, S.A.
Les Franqueses Del Valles Sandoz Industrial Products S.A.
India
Navi Mumbai Sandoz Private Limited





12. TEVA

Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Terazosin Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE

tablet Discontinued ORAL N/A May 18, 2000
EQ 5MG BASE

tablet Discontinued ORAL N/A May 18, 2000
EQ 2MG BASE

tablet Discontinued ORAL N/A May 18, 2000
EQ 1MG BASE

tablet Discontinued ORAL N/A May 18, 2000


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Miami Teva Branded Pharmaceutical Products R & D, Inc.
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Fort Dodge TEVA Animal Health Inc
Horsham Teva Branded Pharmaceutical Products R&D
India
Gajraula, Amroha Teva API India Private Ltd.
Bhind Teva API India Ltd- Malanpur
Canada
Markham Teva Canada Limited
Stouffville Teva Canada Limited
Scarborough Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.